Cardio-Oncology: Managing Cardiovascular Risks in Cancer Patients

27 Visioni

Grazie! Condividilo con i tuoi amici!

Non hai gradito questo video. Grazie per il feedback!

Published Nov 4, 2025

The intersection of cancer and cardiovascular health is becoming increasingly crucial. Dr. Christine Brezden-Masley sheds light on the growing collaboration between oncology and cardiology at the Global Cardio-Oncology Summit 2025.
With the rapid evolution of cancer therapies, such as cell and gene therapies, multispecific antibodies, and antibody-drug conjugates (ADCs), survival rates are improving, but cardiotoxic effects are a growing concern. As the global research pipeline accelerates, tracking the cardiac impact of these new treatments becomes more challenging.
This video explores the importance of early cardiology involvement in cancer care, highlighting clinical cases where timely interventions made a difference. It discusses the expanding spectrum of cardiotoxicity associated with novel therapeutics and the ongoing research, like the SCHOLAR-2 trial, to address these challenges.
Additionally, the rise of survivorship emphasizes lifestyle interventions, such as exercise, which can reduce cardiac and oncologic risks. The Canadian Cardio-Oncology Network (CCON) serves as a model for successful collaboration, ensuring patients receive optimal cancer treatment without compromising heart health.